Basit öğe kaydını göster

Nitric oxide mediated effects of nebivolol in cardiorenal syndrome

dc.contributor.authorSemen, Onder
dc.contributor.authorMercanoglu, Guldem
dc.date.accessioned2021-03-06T11:55:41Z
dc.date.available2021-03-06T11:55:41Z
dc.date.issued2019
dc.identifier.citationMercanoglu G., Semen O., "Nitric oxide mediated effects of nebivolol in cardiorenal syndrome", IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, cilt.22, ss.1314-1324, 2019
dc.identifier.issn2008-3866
dc.identifier.othervv_1032021
dc.identifier.otherav_f16cc383-affb-4e1c-8568-aec0fa608a65
dc.identifier.urihttp://hdl.handle.net/20.500.12627/158388
dc.identifier.urihttps://doi.org/10.22038/ijbms.2019.37400.8927
dc.description.abstractObjective(s): Despite several proposed mechanisms for the pathophysiology of cardiorenal syndrome (CRS), the exact mechanism remains unclear. Nitrosative stress has been argued as a key mechanism recently. Nebivolol is a beta-blocker with nitric oxide (NO)-releasing effect. In the present study, NO-mediated effects of two different treatment regimes of nebivolol in CRS were studied.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectTemel Bilimler
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.titleNitric oxide mediated effects of nebivolol in cardiorenal syndrome
dc.typeMakale
dc.relation.journalIRANIAN JOURNAL OF BASIC MEDICAL SCIENCES
dc.contributor.departmentUniv Hlth Sci , ,
dc.identifier.volume22
dc.identifier.issue11
dc.identifier.startpage1314
dc.identifier.endpage1324
dc.contributor.firstauthorID270079


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster